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 Vitamin D – what is normal according to latest 
research and how should we deal with it? 
 Editor – This interesting article summarised the public health 
concern presented by vitamin D deficiency. The observational 
data that links vitamin D deficiency to many chronic diseases 
demonstrates a potential impact extending far beyond 
traditionally recognised endocrine effects on bone health. 
The benefits of vitamin D supplementation, in the absence of 
randomised controlled trial data, are currently yet to be fully 
defined. 
 The author advocates ‘a targeted, rather than population-
based screening approach to vitamin D testing’, but adds 
that ‘empirical supplementation of at risk groups should be 
considered’. 1 Any strategy that includes blanket vitamin D 
supplementation should be approached with caution: certain 
individuals in the population will have a genetic predisposition 
to vitamin D toxicity, unmasked only through higher vitamin 
D intake. 
 In the 1950s, routine supplementation of formula milk 
products with vitamin D 3 , in an effort to prevent rickets, 
led to a sudden increase in infants presenting with 
idiopathic infantile hypercalcaemia, in some cases proving 
fatal. 2 Almost 60 years later, the discovery of loss-of-
function mutations in  CYP24A1 , which encodes vitamin D 
24-hydroxylase – an enzyme with a key role in vitamin D 
catabolism – finally linked these events. 3 Furthermore, an 
adult cohort who present with calcium-containing renal 
stones and nephrocalcinosis are recognised to carry  CYP24A1 
mutations. 4  At present, the population frequency of  CYP24A1 
variants has not been established. 5 The rarity of these 
presentations often leads to delayed diagnosis, a feature that 
will hopefully change with increased awareness and easier 
access to diagnostic testing. 
 As research into vitamin D supplementation expands, we 
must be careful to tailor our treatment towards each individual, 
and remember that Vitamin D supplements are not the answer 
for everyone. ■ 
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 Viral arthritis 
 Editor – I am grateful to Marks and Marks 1 for their excellent 
overview of viral arthritis, which provided many useful clinical 
pointers. Viral arthritis acquired abroad will continue to 
increase in line with the ever-expanding number of travelers 
visiting or returning to the UK, especially from tropical climes. 2 
As noted in the review, aetiology of viral arthritis includes 
alphaviruses such as Chikungunya and also flaviviruses such as 
Dengue. There is another topical flavivirus that is relevant for 
the generalist faced with a returned traveler with a fever, rash 
and arthralgia/arthritis: Zika. 
 Zika virus has been described as a ‘new global health 
threat’ for 2016. 3 While the majority of those infected with 
Zika will be asymptomatic, there are major concerns about 
a possible association between Zika infection in pregnant 
women and congenital microcephaly. 4 Twenty one cases 
of Zika have been diagnosed in the UK since April 2015 in 
travellers returning from affected countries (predominantly 
the Americas and the Caribbean). 5 Returning travellers 
presenting with a maculopapular rash and/or fever with at 
least one of the following symptoms (not explained by other 
medical conditions) meet the World Health Organization 
criteria of a suspected case: conjunctivitis, arthralgia, or 
arthritis. 6 Other symptoms may include itching/pruritus, 
headache, myalgia, lower back pain, and retro-orbital pain – 
all of which are compatible with a diagnosis of Dengue fever 
or Chikungunya. 5 
 Public Health England provides comprehensive guidance 
on Zika virus infection, including a clinical algorithm of 
investigation of suspected cases and exposed pregnant women. 5 
Management of people with Zika virus infection is supportive, 
with intravenous fluids if necessary and paracetamol for fever 
and arthralgia/arthritis. It should be noted that non-steroid 
anti-inflammatory agents are best avoided until the diagnosis of 
Dengue has been excluded, because of bleeding risk. 
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 With expanding global travel, emerging and tropical 
infections are becoming ever more pertinent to and 
prevalent in day-to-day primary and secondary care practice 
in the UK. Clinicians should remain vigilant to the 1% of 
acute arthritis cases of viral aetiology, which include Zika 
virus infection. ■
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